3 Reasons It's Not Too Late to Buy Co-Diagnostics

Co-Diagnostics (NASDAQ: CODX) is up a ridiculous 1,240% this year, but the stock has dropped more than 45% in the past three months. It's probably right to wonder if its run is over, and whether it's still a good time to buy the molecular-diagnostics company, which marketed highly accurate tests for COVID-19 this year.

When we consider the factors leading to Co-Diagnostics 2020 climb, it all seems to boil down to the same question for prospective investors -- although it's done it before, can Co-Diagnostics really go higher in the future? Here are three reasons why I think it will.

IMAGE SOURCE: GETTY IMAGES.

Continue reading

Source Fool.com